TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
UPB

Upstream Bio, Inc.

Healthcare · Biotechnology · —

5.30$ +0.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow UPB
Line item 2022 2023 2024 2025
-1,569.4% -1,593.5% -2,496.7% -4,669.8%
0.6% 2.5% 3.8% -46.0%
105.5% 144.0% 253.3% 362.0%
281.5% -180.9% 79.0% 20.6%
6.8% 6.1% 21.6% 5.8%
-6.8% -3,480.8% -2,509.9% -3,275.4%
822.0% 5,443.3% 17,675.5% 85.5%
-754.1% 369.0% 12,668.9% -7,859.6%
-1,576.2% -1,599.6% -2,518.3% -4,669.8%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?